These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 16635965)

  • 21. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimalarial constituents from Nauclea orientalis (L.) L.
    He ZD; Ma CY; Zhang HJ; Tan GT; Tamez P; Sydara K; Bouamanivong S; Southavong B; Soejarto DD; Pezzuto JM; Fong HH
    Chem Biodivers; 2005 Oct; 2(10):1378-86. PubMed ID: 17191939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measuring the distribution of density and tabletting force in pharmaceutical tablets by chemical imaging.
    Ellison CD; Ennis BJ; Hamad ML; Lyon RC
    J Pharm Biomed Anal; 2008 Sep; 48(1):1-7. PubMed ID: 18539424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Properties of Delonix regia seed gum as a novel tablet binder.
    Adetogun GE; Alebiowu G
    Acta Pol Pharm; 2009; 66(4):433-8. PubMed ID: 19702177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of surface color as an expedient QC method for the detection of deviations in tablet hardness.
    Siddiqui A; Nazzal S
    Int J Pharm; 2007 Aug; 341(1-2):173-80. PubMed ID: 17499947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and evaluation of floating multi-layer coated tablets based on gas formation.
    Sungthongjeen S; Sriamornsak P; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2008 May; 69(1):255-63. PubMed ID: 17967527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of compression forces on tablets disintegration by AC Biosusceptometry.
    Corá LA; Fonseca PR; Américo MF; Oliveira RB; Baffa O; Miranda JR
    Eur J Pharm Biopharm; 2008 May; 69(1):372-9. PubMed ID: 18164605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The presence of microorganisms in some common excipients used in tablet formulation.
    Obuekwe IF; Eichie F
    Acta Pol Pharm; 2006; 63(2):121-5. PubMed ID: 17514875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Process design applied to optimise a directly compressible powder produced via a continuous manufacturing process.
    Gonnissen Y; Gonçalves SI; De Geest BG; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2008 Mar; 68(3):760-70. PubMed ID: 17964129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A material-sparing method for simultaneous determination of true density and powder compaction properties--aspartame as an example.
    Sun CC
    Int J Pharm; 2006 Dec; 326(1-2):94-9. PubMed ID: 16926076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Entrapment of andrographolide in cross-linked alginate pellets: I. Formulation and evaluation of associated release kinetics.
    Shariff A; PK M; KLK P; M M
    Pak J Pharm Sci; 2007 Jan; 20(1):1-9. PubMed ID: 17337420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compressibility and compactibility of granules produced by wet and dry granulation.
    Bacher C; Olsen PM; Bertelsen P; Sonnergaard JM
    Int J Pharm; 2008 Jun; 358(1-2):69-74. PubMed ID: 18407441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a rapidly dispersing tablet of a poorly wettable compound: formulation DOE and mechanistic study of effect of formulation excipients on wetting of celecoxib.
    He X; Barone MR; Marsac PJ; Sperry DC
    Int J Pharm; 2008 Apr; 353(1-2):176-86. PubMed ID: 18207339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of multivariate methods to compression behavior evaluation of directly compressible materials.
    Haware RV; Tho I; Bauer-Brandl A
    Eur J Pharm Biopharm; 2009 May; 72(1):148-55. PubMed ID: 19084596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antinociceptive, anti-inflammatory and antipyretic properties of the aqueous extract of Bauhinia purpurea leaves in experimental animals.
    Zakaria ZA; Wen LY; Abdul Rahman NI; Abdul Ayub AH; Sulaiman MR; Gopalan HK
    Med Princ Pract; 2007; 16(6):443-9. PubMed ID: 17917444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization of poorly compactable drug tablets manufactured by direct compression using the mixture experimental design.
    Martinello T; Kaneko TM; Velasco MV; Taqueda ME; Consiglieri VO
    Int J Pharm; 2006 Sep; 322(1-2):87-95. PubMed ID: 16806756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of the SeDeM Diagram and a new mathematical equation in the design of direct compression tablet formulation.
    Suñé-Negre JM; Pérez-Lozano P; Miñarro M; Roig M; Fuster R; Hernández C; Ruhí R; García-Montoya E; Ticó JR
    Eur J Pharm Biopharm; 2008 Aug; 69(3):1029-39. PubMed ID: 18367387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticonvulsant, anxiolytic, and sedative properties of the roots of Nauclea latifolia Smith in mice.
    Ngo Bum E; Taiwe GS; Moto FC; Ngoupaye GT; Nkantchoua GC; Pelanken MM; Rakotonirina SV; Rakotonirina A
    Epilepsy Behav; 2009 Aug; 15(4):434-40. PubMed ID: 19560975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Valeriana officinalis Dry Plant Extract for Direct Compression: Preparation and Characterization.
    Gallo L; Ramírez-Rigo MV; Piña J; Palma S; Allemandi D; Bucalá V
    Sci Pharm; 2012; 80(4):1013-26. PubMed ID: 23264947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.